Zacks Investment Research Lowers Exponent (EXPO) to Hold

Exponent (NASDAQ:EXPO) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a report released on Tuesday.

According to Zacks, “Exponent, Inc., is a multidisciplinary organization of scientists, physicians, engineers and business consultants performing in-depth scientific research and analysis in over 90 technical disciplines. The company is an engineering and scientific consulting firm providing solutions to complex problems. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future. The Company serves clients in the automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology and other sectors. “

Other equities analysts have also issued reports about the company. Cantor Fitzgerald restated a “buy” rating and set a $82.00 price target on shares of Exponent in a research note on Sunday, November 5th. BidaskClub lowered Exponent from a “buy” rating to a “hold” rating in a research note on Saturday, December 9th. Finally, SunTrust Banks restated a “hold” rating and set a $77.00 price target on shares of Exponent in a research note on Thursday, October 19th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the company. The company presently has an average rating of “Hold” and an average target price of $80.00.

Exponent (NASDAQ EXPO) traded up $0.55 during midday trading on Tuesday, reaching $72.40. The company’s stock had a trading volume of 77,900 shares, compared to its average volume of 101,088. Exponent has a one year low of $55.75 and a one year high of $77.15. The company has a market capitalization of $1,854.50, a price-to-earnings ratio of 39.26 and a beta of 0.57.

Exponent (NASDAQ:EXPO) last posted its quarterly earnings data on Wednesday, October 18th. The business services provider reported $0.54 EPS for the quarter, topping analysts’ consensus estimates of $0.45 by $0.09. The business had revenue of $87.60 million for the quarter, compared to analyst estimates of $79.69 million. Exponent had a return on equity of 17.21% and a net margin of 16.46%. The firm’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.42 earnings per share. equities analysts anticipate that Exponent will post 2.09 earnings per share for the current year.

In related news, CEO Paul R. Johnston sold 3,052 shares of the business’s stock in a transaction that occurred on Tuesday, September 26th. The shares were sold at an average price of $73.11, for a total value of $223,131.72. Following the completion of the transaction, the chief executive officer now owns 35,342 shares in the company, valued at approximately $2,583,853.62. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Paul R. Johnston sold 4,000 shares of the business’s stock in a transaction that occurred on Thursday, September 21st. The stock was sold at an average price of $72.42, for a total transaction of $289,680.00. Following the completion of the transaction, the chief executive officer now owns 38,394 shares of the company’s stock, valued at approximately $2,780,493.48. The disclosure for this sale can be found here. Insiders sold a total of 10,052 shares of company stock worth $734,842 over the last three months. 2.80% of the stock is owned by company insiders.

A number of hedge funds have recently bought and sold shares of EXPO. Riverhead Capital Management LLC raised its position in shares of Exponent by 89.7% during the 2nd quarter. Riverhead Capital Management LLC now owns 1,897 shares of the business services provider’s stock valued at $111,000 after acquiring an additional 897 shares during the last quarter. Tower Research Capital LLC TRC bought a new stake in shares of Exponent during the 2nd quarter valued at $121,000. Advisory Services Network LLC bought a new stake in shares of Exponent during the 1st quarter valued at $123,000. Advisor Group Inc. raised its position in shares of Exponent by 15.4% during the 2nd quarter. Advisor Group Inc. now owns 2,131 shares of the business services provider’s stock valued at $124,000 after acquiring an additional 284 shares during the last quarter. Finally, Victory Capital Management Inc. raised its position in shares of Exponent by 3.1% during the 3rd quarter. Victory Capital Management Inc. now owns 2,518 shares of the business services provider’s stock valued at $129,000 after acquiring an additional 76 shares during the last quarter. Hedge funds and other institutional investors own 88.58% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Zacks Investment Research Lowers Exponent (EXPO) to Hold” was reported by American Banking News and is the sole property of of American Banking News. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The correct version of this story can be read at https://www.americanbankingnews.com/2017/12/19/zacks-investment-research-lowers-exponent-expo-to-hold.html.

Exponent Company Profile

Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.

Get a free copy of the Zacks research report on Exponent (EXPO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply